Science News

... from universities, journals, and other research organizations

Implantable Birth Control New Option For Women

Nov. 11, 2006 — A single-rod implantable contraceptive that has been available in other countries since 1998 is now being used in the United States, including in the Cincinnati area.


Share This:

The implant is injected underneath the skin of the upper arm during an in-office procedure that takes about one minute. The implant, the size of a matchstick, releases a steady stream of the female hormone etonogestrel (Implanon) over a three-year period.

"This is a great option for women who can't take pills or don't easily tolerate other birth control options like IUDs and the patch," says University of Cincinnati (UC) fertility expert and contraceptive researcher Michael Thomas, MD.

Etonogestrel works by thickening the cervical mucus, which prevents sperm from fertilizing an egg and also stops any egg that does get fertilized from implanting itself in the uterine wall. Etonogestrel completely inhibits the release of eggs from the ovaries during the first two years. In the third year, it begins to lose its effectiveness.

"Women who use this form of birth control don't have to worry about taking a pill every day or changing their birth control ring every month," says Thomas. "It's a great long-term option."

Thomas cautions, however, that the implant is not for everyone. "Unfortunately, irregular bleeding is a side effect. Women have to be willing to tolerate this possibility. Also, women who experience heavy bleeding or are significantly overweight may want to consider other birth control options."

Thomas is a physician with UC's Center for Reproductive Health, which has expertise in infertility, menopause and endocrinological disorders. Established in 1988, it's the only comprehensive patient care and research unit focused on women's health in the Cincinnati area. To contact the center, call (513) 585-2355. To learn about birth control studies at UC, visit http://www.researchforwomen.com or call (513) 584-4100.

Thomas has no financial interest in Organon USA, the manufacturer of Implanon.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

|

Story Source:

The above story is reprinted from materials provided by University Of Cincinnati.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


APA

MLA

Note: If no author is given, the source is cited instead.

Search ScienceDaily

Number of stories in archives: 137,306

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.

Recommend ScienceDaily on Facebook, Twitter, and Google:

Other social bookmarking and sharing services:

|

 
  more breaking science news

Social Networks


Recommend ScienceDaily on Facebook, Twitter, and Google +1:

Other social bookmarking and sharing tools:

|

Breaking News

... from NewsDaily.com

In Other News ...

Science Video News


Saving Hearts with LVADs

First used for patients awaiting heart transplants, left-ventricular assist devices (LVADs) are now enhancing the quality of life of patients with. ...  > full story

Strange Science News

 

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

Post this page to your favorite social bookmarking site:
Include this item in your blog or web site:
Cite this article in your essay, paper, or report:
Email this page's link to a friend or colleague: